ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00954876
Recruitment Status : Withdrawn (Study has been terminated due to lack of accrual.)
First Posted : August 7, 2009
Last Update Posted : January 31, 2012
Sponsor:
Collaborator:
ImClone LLC
Information provided by:
Translational Drug Development

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : January 2010
  Actual Study Completion Date : January 2010